Picture of Union Korea Pharm Co logo

080720 Union Korea Pharm Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousMicro Cap

Annual cashflow statement for Union Korea Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-11,109-932-18,156-20,872-30,820
Depreciation
Amortisation
Non-Cash Items3,5741,15414,0417,94327,619
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital5,224-9,2791,58810,467263
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities1,915-5,0631,362415-1,134
Capital Expenditures-7,268-3,455-2,530-955-121
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-805-72.84221331,249
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Cash from Investing Activities-8,073-3,528-2,108-8211,128
Financing Cash Flow Items500
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities25,241-6,0251,338-1,876-1,187
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash19,101-14,647567-2,254-1,200